Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study

BACKGROUND AND OBJECTIVES: A high systemic immune-inflammation index (SIII) at diagnosis of various cancers, including pancreatic cancer, is associated with poor prognosis. The impact of FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) chemotherapy or stereotactic body radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales: van ‘t Land, Freek R., Aziz, Mohammad H., Michiels, Nynke, Mieog, J. Sven D., Bonsing, Bert A., Luelmo, Saskia A.C., Homs, Marjolein Y.V., Groot Koerkamp, Bas, Papageorgiou, Grigorios, van Eijck, Casper H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631500/
https://www.ncbi.nlm.nih.gov/pubmed/37010512
http://dx.doi.org/10.1097/SLA.0000000000005865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631500/
https://www.ncbi.nlm.nih.gov/pubmed/37010512
http://dx.doi.org/10.1097/SLA.0000000000005865

Ejemplares similares